Managing allergic rhinitis and asthma: Analyzing the role of Montelukast-Levocetirizine combination Dr. Kamal Kant Kohli15 Dec 2021 11:57 AM ISTAllergic rhinitis (AR) is now being acknowledged as a global health burden with estimates highlighting that 10%-25% of the population worldwide is...
Role of Fluconazole in Superficial Fungal Infections Dr. Manjunath Shenoy14 Dec 2021 11:24 AM ISTRole of Fluconazole in Superficial Fungal Infections Superficial fungal infection is a worldwide health problem affecting more than 25% of the...
Understanding Probiotics: Why Multistrain rules over Monostrain Manoj K Joshi10 Dec 2021 11:00 AM ISTIn recent years, the intestinal microbiota has been found to significantly influence multiple biological processes relevant for human health and...
What was the optimal dose of pirfenidone in large studies on idiopathic pulmonary fibrosis? Dr. Kamal Kant Kohli9 Dec 2021 12:00 PM ISTIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal lung disease that is characterized by the irreversible loss of lung function....
Managing Herpes spectrum: "Hit early" and "Hit hard" with antiviral acyclovir dr. Abhimanyu Uppal7 Dec 2021 12:39 PM ISTAn estimated 3.7 billion people under age 50 (67%) have Herpes simplex virus infection (HSV) -1 infection globally. An estimated 491 million people...
Pediatric Pyrexia management and Clinical Practice: Review Dr. Kamal Kant Kohli3 Dec 2021 12:45 PM ISTFever in children is a common cause of primary care consultations and hospital admissions, and estimates show that it affects 70% of all pre-school...
Casirivimab and Imdevimab Antibody combination for COVID-19 Prophylaxis Dr. Kamal Kant Kohli30 Nov 2021 12:33 PM ISTCasirivimab and Imdevimab are two non-competing, high-affinity human IgG1 anti-SARS- CoV-2 monoclonal antibodies, which bind specifically to the...
Esomeprazole-prokinetic combination: A novel approach to managing GERD Dr. Shubham Vatsya27 Nov 2021 12:03 PM ISTGastroesophageal reflux disease (GERD) is emerging as a major health concern, having a strikingly high prevalence rate of 7.6% to...
Montelukast - Preferred Choice in Long Term Management of Respiratory Allergies Dr. Kamal Kant Kohli25 Nov 2021 11:20 AM ISTRespiratory Allergies in India - Unique Challenges & Need for Early Interventions An estimated 300 million people worldwide have asthma, with...
PPIs induced Risk of Recurrent Clostridium difficile Infections and Rationale for Use of Probiotics: Review Spandan Bhadury23 Nov 2021 9:15 AM ISTClostridium difficile associated diarrhea (CDAD) in India is still an under-recognized etiology of diarrhea. This is largely due to lack of clinical...
Combining ARBs, CCBs and Diuretics in controlling Resistant Hypertension in CV patients: Review Prem Aggarwal12 Nov 2021 12:57 PM ISTA significant increase in resistant hypertension (RH) has been documented in the last decade, with epidemiological data suggesting that the rise has...
Combatting allergic rhinitis-Why prefer Fexofenadine - Montelukast over Bilastine-Montelukast? dr. Abhimanyu Uppal9 Nov 2021 12:31 PM ISTWith the COVID restrictions getting unlocked in almost all states of India along with the approaching season of allergies, physicians across the...
